Skip to main content

Table 4 Classification by platelet counts of all serious bleeding events during infusion period in all clinical trials

From: Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis

 

SBEs during infusion period

Platelets (×103/mm3)1

Events (n)

Cumulative %

≤ 20

5

9.4

>20 to ≤ 30

6

20.8

>30 to ≤ 50

11

41.5

>50 to ≤ 100

12

64.2

>100

19

100.0

Not available

26

 

Total

79

 
  1. A total of 2786 patients treated with drotrecogin alfa (activated) infusion were included in this analysis. 1Platelet counts were ecorded within the preceding 24 hours of a serious bleeding event (SBE).
Back to article page

Critical Care

ISSN: 1364-8535